85 related articles for article (PubMed ID: 9575422)
21. [Detection of abnormal numbers of chromosome 8 with interphase fluorescence in situ hybridization in hematologic malignancies].
Wang HP; Li GX; Qiao ZH; Wang HW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):395-7. PubMed ID: 15300644
[TBL] [Abstract][Full Text] [Related]
22. Multitarget FISH and LOH analyses at chromosome 3p in non-small cell lung cancer and adjacent bronchial epithelium.
Woenckhaus M; Grepmeier U; Wild PJ; Merk J; Pfeifer M; Woenckhaus U; Stoelcker B; Blaszyk H; Hofstaedter F; Dietmaier W; Hartmann A
Am J Clin Pathol; 2005 May; 123(5):752-61. PubMed ID: 15981815
[TBL] [Abstract][Full Text] [Related]
23. Cutaneous T-cell lymphoma-associated lung cancers show chromosomal aberrations differing from primary lung cancer.
Hahtola S; Burghart E; Puputti M; Karenko L; Abdel-Rahman WM; Väkevä L; Jeskanen L; Virolainen S; Karvonen J; Salmenkivi K; Kinnula V; Joensuu H; Peltomäki P; Klein CA; Ranki A
Genes Chromosomes Cancer; 2008 Feb; 47(2):107-17. PubMed ID: 17985357
[TBL] [Abstract][Full Text] [Related]
24. Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer.
Jeanmart M; Lantuejoul S; Fievet F; Moro D; Sturm N; Brambilla C; Brambilla E
Clin Cancer Res; 2003 Jun; 9(6):2195-203. PubMed ID: 12796386
[TBL] [Abstract][Full Text] [Related]
25. Smoking molecular damage in bronchial epithelium.
Wistuba II; Mao L; Gazdar AF
Oncogene; 2002 Oct; 21(48):7298-306. PubMed ID: 12379874
[TBL] [Abstract][Full Text] [Related]
26. Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention.
Wiest JS; Franklin WA; Drabkin H; Gemmill R; Sidransky D; Anderson MW
J Cell Biochem Suppl; 1997; 28-29():64-73. PubMed ID: 9589350
[TBL] [Abstract][Full Text] [Related]
27. Molecular cytogenetic alterations in the early stage at human bronchial epithelial cell carcinogenesis.
Dong XY; Lu YJ; Tong T; Wang YJ; Guo SP; Bai JF; Han NJ; Cheng SJ
J Cell Biochem Suppl; 1997; 28-29():74-80. PubMed ID: 9589351
[TBL] [Abstract][Full Text] [Related]
28. FISH cytogenetics and prognosis in breast and non-small cell lung cancers.
Massoner A; Augustin F; Duba HC; Zojer N; Fiegl M
Cytometry B Clin Cytom; 2004 Nov; 62(1):52-6. PubMed ID: 15468329
[TBL] [Abstract][Full Text] [Related]
29. Retinoic acid receptor and retinoid X receptor alterations in lung cancer precursor lesions.
Martinet N; Alla F; Farré G; Labib T; Drouot H; Vidili R; Picard E; Gaube MP; Le Faou D; Siat J; Borelly J; Vermylen P; Bazarbachi T; Vignaud JM; Martinet Y
Cancer Res; 2000 Jun; 60(11):2869-75. PubMed ID: 10850430
[TBL] [Abstract][Full Text] [Related]
30. High DNA damage by benzo[a]pyrene 7,8-diol-9,10-epoxide in bronchial epithelial cells from patients with lung cancer: comparison with lung parenchyma.
Rojas M; Marie B; Vignaud JM; Martinet N; Siat J; Grosdidier G; Cascorbi I; Alexandrov K
Cancer Lett; 2004 Apr; 207(2):157-63. PubMed ID: 15072824
[TBL] [Abstract][Full Text] [Related]
31. Molecular alterations at 9q33.1 and polyploidy in asbestos-related lung cancer.
Nymark P; Kettunen E; Aavikko M; Ruosaari S; Kuosma E; Vanhala E; Salmenkivi K; Pirinen R; Karjalainen A; Knuutila S; Wikman H; Anttila S
Clin Cancer Res; 2009 Jan; 15(2):468-75. PubMed ID: 19147751
[TBL] [Abstract][Full Text] [Related]
32. Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations.
Zhang FF; Arber DA; Wilson TG; Kawachi MH; Slovak ML
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2317-28. PubMed ID: 9815630
[TBL] [Abstract][Full Text] [Related]
33. Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer.
Shao L; Lerner SL; Bondaruk J; Czerniak BA; Zeng X; Grossman HB; Spitz MR; Wu X
Genes Chromosomes Cancer; 2004 Dec; 41(4):379-89. PubMed ID: 15390184
[TBL] [Abstract][Full Text] [Related]
34. Comparison between fluorescence in situ hybridization and classical cytogenetics in human tumors.
Virmani AK; Tonk VS; Gazdar AF
Anticancer Res; 1998; 18(3A):1351-6. PubMed ID: 9673339
[TBL] [Abstract][Full Text] [Related]
35. Phenotype and genotype associations of lung carcinoma with atypical adenomatoid hyperplasia, squamous cell dysplasia, and chromosome alterations in non-neoplastic bronchial mucosa.
Kayser K; Kosjerina Z; Goldmann T; Kayser G; Kazmierczak B; Vollmer E
Rom J Morphol Embryol; 2005; 46(1):5-10. PubMed ID: 16286978
[TBL] [Abstract][Full Text] [Related]
36. Lung cancer in never smokers: a review.
Subramanian J; Govindan R
J Clin Oncol; 2007 Feb; 25(5):561-70. PubMed ID: 17290066
[TBL] [Abstract][Full Text] [Related]
37. [Molecular cytopathology of lung cancer--prevalence of genetic alterations and their role in the development of molecular biomarkers].
Grote HJ; Schmiemann V; Böcking A
Verh Dtsch Ges Pathol; 2003; 87():142-9. PubMed ID: 16888906
[TBL] [Abstract][Full Text] [Related]
38. [Study on interphase cytogenetic abnormalities in malignant cells in pleural fluids from lung cancer cases].
Jia D; Zhang Z; Liu S; Cheng S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Aug; 17(4):244-7. PubMed ID: 10932006
[TBL] [Abstract][Full Text] [Related]
39. Relations of the c-myc gene and chromosome 8 in non-small cell lung cancer: analysis by fluorescence in situ hybridization.
Kubokura H; Tenjin T; Akiyama H; Koizumi K; Nishimura H; Yamamoto M; Tanaka S
Ann Thorac Cardiovasc Surg; 2001 Aug; 7(4):197-203. PubMed ID: 11578259
[TBL] [Abstract][Full Text] [Related]
40. Chromosome 9 instability and alterations of p16 gene in squamous cell carcinoma of the lung and in adjacent normal bronchi: FISH and immunohistochemical study.
Dessy E; Rossi E; Berenzi A; Tironi A; Benetti A; Grigolato P
Histopathology; 2008 Mar; 52(4):475-82. PubMed ID: 18315600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
